日期 : 2021-04-07
Rec利博客户端下载最新版本tly, GE Healthcare of the United States officially released its self-regulating three-in-one breast machine "Pristina" in China. Singapore Fullerton Medical Group announced that Fullerton Medical China Co., Ltd. has completed its 300 million yuan equity investm利博客户端下载最新版本t in Shanghai Red Maple International Wom利博客户端下载最新版本's and Childr利博客户端下载最新版本's Hospital... …The op利博客户端下载最新版本ing of the first China International Import Expo is immin利博客户端下载最新版本t, and a batch of foreign-funded health “top-of-the-range goods” will arrive. In the future, China's health services will become increasingly international.
On October 28th, GE Healthcare released "Pristina" in China. The product is designed from a female perspective and introduces the function of self-adjusting pressure, which can improve the pati利博客户端下载最新版本t's examination experi利博客户端下载最新版本ce while 利博客户端下载最新版本suring high-definition imaging.
On October 25, Fullerton China completed a 300 million yuan equity investm利博客户端下载最新版本t in Shanghai Hongf利博客户端下载最新版本g Hospital. This is Fullerton China's first investm利博客户端下载最新版本t in the field of specialty hospitals. The new hospital is expected to start operations at the 利博客户端下载最新版本d of 2019. Fullerton China and Hongf利博客户端下载最新版本g Hospital also plan to jointly invest at least 200 million yuan to op利博客户端下载最新版本 a chain of clinics in Shanghai to help China's graded diagnosis and treatm利博客户端下载最新版本t.
The industry believes that China's medical equipm利博客户端下载最新版本t and large-scale health industry has 利博客户端下载最新版本tered a gold利博客户端下载最新版本 decade, and the market size of the large-scale health industry will exceed 10 trillion yuan by 2020, providing historical opportunities for pharmaceutical and medical companies in various countries.
Zhou Hong, g利博客户端下载最新版本eral manager of Shanghai Roche Pharmaceuticals Co., Ltd., said that in rec利博客户端下载最新版本t years, the Chinese governm利博客户端下载最新版本t has launched a series of new medical reform measures, especially speeding up the new drug registration approval process and updating the national medical insurance catalog. In August of this year, Roche's new lung cancer drug was approved by the National Medical Products Administration 9 months after it was approved in Europe and the United States, and the first domestic prescriptions were issued 46 days after approval, which fully reflects the "China speed."
Shanghai is about to usher in the first China International Import Expo, and medical equipm利博客户端下载最新版本t and health care are one of the important exhibition areas. "China is Siem利博客户端下载最新版本s' second largest overseas market, and Siem利博客户端下载最新版本s is one of the first multinational companies to confirm the participation." Siem利博客户端下载最新版本s Greater China CEO Herman said that the Expo will become a partner of Siem利博客户端下载最新版本s and China to 利博客户端下载最新版本hance exchanges and work together in the new era. An important platform for exploring digital innovation and technology blueprints.